4.3 Article

Binocular benefit following monocular subretinal AAV injection in a mouse model of autosomal dominant retinitis pigmentosa (adRP)

Related references

Note: Only part of the references are listed.
Review Ophthalmology

Genetic treatment for autosomal dominant inherited retinal dystrophies: approaches, challenges and targeted genotypes

Malena Daich Varela et al.

Summary: Inherited retinal diseases (IRDs) have been a significant area of gene therapy development in the past decade, with over 40 clinical trials completed or ongoing. Recently, there has been progress in targeting autosomal dominant diseases, such as retinitis pigmentosa, using novel therapeutic approaches like antisense oligonucleotide therapy. Autosomal dominant IRDs are less common but tend to have milder symptoms and later onset compared to autosomal recessive diseases. Various strategies, including zinc fingers, RNA interference, antisense oligonucleotides, translational read-through therapy, and gene editing, are currently being investigated for their potential in treating IRDs.

BRITISH JOURNAL OF OPHTHALMOLOGY (2023)

Article Biotechnology & Applied Microbiology

CRISPR genome surgery in a novel humanized model for autosomal dominant retinitis pigmentosa

Wen-Hsuan Wu et al.

Summary: This study presents a CRISPR-based gene modification therapy for autosomal dominant retinitis pigmentosa, which has been validated in a humanized mouse model, demonstrating the effectiveness of the treatment and its potential application in other genetic diseases.

MOLECULAR THERAPY (2022)

Article Medicine, Research & Experimental

Gene Therapy for Rhodopsin Mutations

Alfred S. S. Lewin et al.

Summary: Mutations in the RHO gene are a significant cause of autosomal-dominant retinitis pigmentosa. There are two clinical classes of patients - those with early onset and those with slowly progressive disease. Gene therapy can target the mutant gene at the DNA or RNA level, while other therapies aim to preserve photoreceptor viability.

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2022)

Article Medicine, Research & Experimental

Suprachoroidal and Subretinal Injections of AAV Using Transscleral Microneedles for Retinal Gene Delivery in Nonhuman Primates

Glenn Yiu et al.

MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2020)

Article Medicine, Research & Experimental

Labeling Dual Presynaptic Inputs using cFork Anterograde Tracing System

Jun-Young Oh et al.

EXPERIMENTAL NEUROBIOLOGY (2020)

Article Multidisciplinary Sciences

Redistribution of metabolic resources through astrocyte networks mitigates neurodegenerative stress

Melissa L. Cooper et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Article Cell Biology

Bilateral visual improvement with unilateral gene therapy injection for Leber hereditary optic neuropathy

Patrick Yu-Wai-Man et al.

SCIENCE TRANSLATIONAL MEDICINE (2020)

Article Ophthalmology

A cell penetrating peptide from SOCS-1 prevents ocular damage in experimental autoimmune uveitis

Chulbul M. Ahmed et al.

EXPERIMENTAL EYE RESEARCH (2018)

Article Ophthalmology

Gene Therapy for Leber Hereditary Optic Neuropathy

John Guy et al.

OPHTHALMOLOGY (2017)

Article Biotechnology & Applied Microbiology

Highly Efficient Delivery of Adeno-Associated Viral Vectors to the Primate Retina

Shannon E. Boye et al.

HUMAN GENE THERAPY (2016)

Article Medicine, General & Internal

Long-term outcomes of gene therapy for the treatment of Leber's hereditary optic neuropathy

Shuo Yang et al.

EBIOMEDICINE (2016)

Article Ophthalmology

Chemical and material communication between the optic nerves in rats

Shuo Yang et al.

CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2015)

Review Biotechnology & Applied Microbiology

A Comprehensive Review of Retinal Gene Therapy

Shannon E. Boye et al.

MOLECULAR THERAPY (2013)

Article Ophthalmology

Survey of Common Eye Diseases in Laboratory Mouse Strains

Bo Chang et al.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2013)

Article Biotechnology & Applied Microbiology

Suppression and Replacement Gene Therapy for Autosomal Dominant Disease in a Murine Model of Dominant Retinitis Pigmentosa

Sophia Millington-Ward et al.

MOLECULAR THERAPY (2011)

Article Biotechnology & Applied Microbiology

AAV Mediated GDNF Secretion From Retinal Glia Slows Down Retinal Degeneration in a Rat Model of Retinitis Pigmentosa

Deniz Dalkara et al.

MOLECULAR THERAPY (2011)

Article Ophthalmology

The Dependence of Retinal Degeneration Caused by the Rhodopsin P23H Mutation on Light Exposure and Vitamin A Deprivation

Beatrice M. Tam et al.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2010)

Article Biotechnology & Applied Microbiology

Subretinal delivery of recombinant AAV serotype 8 vector in dogs results in gene transfer to neurons in the brain

Knut Stieger et al.

MOLECULAR THERAPY (2008)

Article Biotechnology & Applied Microbiology

Safety in nonhuman primates of ocular AAV2-RPE65, a candidate treatment for blindness in leber congenital amaurosis

Samuel G. Jacobson et al.

HUMAN GENE THERAPY (2006)

Article Biotechnology & Applied Microbiology

AAV2-Mediated ocular gene therapy for infantile neuronal ceroid lipofuscinosis

M Griffey et al.

MOLECULAR THERAPY (2005)

Review Biochemistry & Molecular Biology

Mechanisms of cell death in rhodopsin retinitis pigmentosa: implications for therapy

HF Mendes et al.

TRENDS IN MOLECULAR MEDICINE (2005)

Article Multidisciplinary Sciences

Naturally occurring rhodopsin mutation in the dog causes retinal dysfunction and degeneration mimicking human dominant retinitis pigmentosa

JW Kijas et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)

Article Ophthalmology

Long-term real-time monitoring of adeno-associated virus-mediated gene expression in the rat retina

F Rolling et al.

CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2000)